CSF3 and acute myeloid leukemia: On the other hand, the administration of GCSF into control mice (GCSF), or mice treated with AML-alone (AML+GCSF), CYT-alone (CYT+GCSF), or with combination of AML and CYT (AML+CYT+GCSF) significantly decreased the percentage of STs with apoptotic cells compared to the relevant groups without GCSF 2 weeks post-injection (Figure 4B).